Real-world reports show wide variability: some observational analyses note that about 5% experience sleep disturbances, while a 2025 Care Pharmacy summary found that roughly 30% of patients on Wegovy reported insomnia
Our team requires this because prescribing without it is, frankly, reckless
Slower loss on smaller doses, paired with enough protein and something heavy to lift, is one of the few levers that lets you lose fat while protecting the body you'll be living in at 70
In 2017, liraglutide became the first GLP-1 receptor agonist approved by the FDA to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, based on results from the LEADER trial
Intravenous Administration: Delivered directly into the bloodstream, this method is typically used for individuals with certain conditions, such as diabetes or Parkinsons disease
10.3390/nu8100606 56